Codes / ICD10CM / K71.50

K71.50 Toxic liver disease with chronic active hepatitis without ascites

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic Liver Disease with Chronic Active Hepatitis without Ascites (ICD-10 Code: K71.50)

Summary

Toxic liver disease with chronic active hepatitis without ascites is a condition characterized by liver inflammation and damage due to exposure to harmful substances, resulting in persistent hepatitis without the presence of abdominal fluid accumulation (ascites). This condition involves ongoing liver injury and impaired function, requiring careful monitoring and management.

Causes

The condition is caused by exposure to substances toxic to the liver, including certain medications, chemicals, or environmental agents. These toxins can trigger an inflammatory response, leading to chronic active hepatitis. Common triggers include hepatotoxic drugs, industrial chemicals, or prolonged exposure to toxins that damage liver cells over time.

Risk Factors

  • Prolonged or high-dose use of hepatotoxic medications
  • Excessive alcohol consumption
  • Occupational or environmental exposure to liver-damaging chemicals
  • Pre-existing liver conditions that reduce metabolic capacity
  • Genetic factors affecting drug or toxin metabolism

Symptoms

  • Jaundice (yellowing of skin or eyes)
  • Dark urine
  • Abdominal pain (especially upper right quadrant)
  • Fatigue and weakness
  • Nausea or vomiting
  • Loss of appetite
  • Enlarged liver (hepatomegaly)

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests (e.g., liver function tests, bilirubin levels, and inflammatory markers), imaging studies (e.g., ultrasound or MRI), and sometimes liver biopsy to assess the extent of inflammation and damage. A thorough history of substance exposure is critical for identifying the underlying cause.

Treatment Options

  • Discontinuation of the toxic substance or drug
  • Medications to reduce inflammation (e.g., corticosteroids in select cases)
  • Nutritional support and liver-protective agents
  • Management of symptoms (e.g., antiemetics for nausea)
  • Monitoring for progression or complications

Prognosis and Follow-Up

Prognosis depends on the extent of liver damage, the cause of toxicity, and timely intervention. With appropriate management, some patients may experience improvement, while others may develop chronic liver disease. Regular follow-up with liver function tests and imaging is essential to monitor for progression or complications.

Complications

  • Progression to cirrhosis
  • Liver failure
  • Increased risk of liver cancer
  • Persistent inflammation leading to fibrosis

Lifestyle & Prevention

  • Avoid hepatotoxic substances, including certain medications and alcohol
  • Use protective measures in occupational settings with chemical exposure
  • Maintain a balanced diet and avoid excessive alcohol consumption
  • Follow prescribed medication guidelines and report any adverse effects promptly

When to Seek Professional Help

Seek medical attention if you experience symptoms such as jaundice, severe abdominal pain, persistent fatigue, or unexplained weight loss, especially if you have a history of toxin exposure or liver disease.

Tips for Medical Coders

When coding K71.50, ensure documentation supports the presence of toxic liver disease with chronic active hepatitis and explicitly notes the absence of ascites. Verify that the clinical record includes details about the toxic exposure, liver function test results, and any relevant imaging or biopsy findings to confirm the diagnosis.

Book a walkthrough

K71.50 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.